Register

Institutional Sign In

Go
Home » Companies » Pharmaceutical in Germany » B Braun Melsungen

B Braun Melsungen

B Braun Melsungen's Cash & Cash Equivalents rose 12.6% yoy to EUR 74.8 mil in 2018

By Helgi Library - April 2, 2020

B Braun Melsungen's total assets reached EUR 9,224 mil at the end of 2018, up 8.19% compared to the previous year. ...

Profit Statement 2016 2017 2018
Sales EUR mil 6,471 6,789 6,908
Gross Profit EUR mil 5,251 5,455 5,576
EBITDA EUR mil 974 957 929
EBIT EUR mil 596 546 497
Financing Cost EUR mil 69.6 70.0 69.0
Pre-Tax Profit EUR mil 528 514 452
Net Profit EUR mil 373 393 311
Balance Sheet 2016 2017 2018
Total Assets EUR mil 7,982 8,526 9,224
Non-Current Assets EUR mil 5,413 5,836 6,332
Current Assets EUR mil 2,569 2,690 2,892
Working Capital EUR mil 1,709 1,776 1,881
Shareholders' Equity EUR mil 3,172 3,436 3,700
Liabilities EUR mil 4,810 5,090 5,525
Total Debt EUR mil 1,992 2,225 2,451
Net Debt EUR mil 1,902 2,158 2,376
Ratios 2016 2017 2018
ROE % 12.3 11.9 8.73
ROCE % 5.47 5.34 3.94
Gross Margin % 81.1 80.4 80.7
EBITDA Margin % 15.0 14.1 13.4
EBIT Margin % 9.21 8.05 7.20
Net Margin % 5.77 5.79 4.51
Net Debt/EBITDA 1.95 2.26 2.56
Net Debt/Equity 0.600 0.628 0.642
Cost of Financing % 3.56 3.32 2.95
Cash Flow 2016 2017 2018
Total Cash From Operations EUR mil 836 679 643
Total Cash From Investing EUR mil -740 -747 -794
Total Cash From Financing EUR mil 96.2 -68.3 -151
Net Change In Cash EUR mil 192 -137 -302
Cash Conversion Cycle days 254 240 271
Cash Earnings EUR mil 751 803 743
Free Cash Flow EUR mil 96.2 -68.3 -151

Get all company financials in excel:

Download Sample   $19.99

summary Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
income statement                                      
Sales EUR mil                         5,048 5,170 5,430 6,130 6,471    
Gross Profit EUR mil                         4,130 4,230 4,419 4,943 5,251    
EBIT EUR mil                         494 492 435 503 596    
Net Profit EUR mil                         273 294 295 305 373    
ROE %                         12.5 12.5 11.8 11.2 12.3    
EBIT Margin %                         9.78 9.53 8.01 8.21 9.21    
Net Margin %                         5.40 5.68 5.44 4.98 5.77    
Employees                         46,559 49,889 54,017 55,719 58,037    
balance sheet                                      
Total Assets EUR mil                         5,484 6,080 6,767 7,266 7,982    
Non-Current Assets EUR mil                         3,366 3,972 4,437 4,848 5,413    
Current Assets EUR mil                         2,118 2,108 2,330 2,419 2,569    
Shareholders' Equity EUR mil                         2,259 2,445 2,564 2,900 3,172    
Liabilities EUR mil                         3,224 3,635 4,203 4,366 4,810    
Non-Current Liabilities EUR mil                         1,918 1,988 2,595 2,477 2,751    
Current Liabilities EUR mil                         1,306 1,646 1,608 1,889 2,059    
Net Debt/EBITDA                         1.63 2.20 2.35 2.15 1.95    
Net Debt/Equity                         0.558 0.710 0.690 0.641 0.600    
Cost of Financing % ...                       5.43 4.16 3.99 3.77 3.56    
cash flow                                      
Total Cash From Operations EUR mil                         718 541 836 717 836    
Total Cash From Investing EUR mil                         -502 -567 -663 -696 -740    
Total Cash From Financing EUR mil                         216 -25.8 173 21.3 96.2    
Net Change In Cash EUR mil                         432 -51.7 347 42.6 192    
valuation                                      
Number Of Shares mil                         19.4 19.4 19.4 19.4 19.4    
Earnings Per Share (EPS) EUR                         14.1 15.1 15.2 15.7 19.2    
Book Value Per Share EUR                         116 126 132 149 163    
Earnings Per Share Growth % ...                       14.2 7.74 0.470 3.48 22.2    
Book Value Per Share Growth % ...                       7.52 8.22 4.87 13.1 9.36    
income statement Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
income statement                                      
Sales EUR mil                         5,048 5,170 5,430 6,130 6,471    
Cost of Goods & Services EUR mil                         918 939 1,010 1,187 1,220    
Gross Profit EUR mil                         4,130 4,230 4,419 4,943 5,251    
Staff Cost EUR mil                         1,834 1,885 2,031 2,260 2,388    
Other Cost EUR mil                         1,522 1,555 1,635 1,818 1,889    
EBITDA EUR mil                         773 790 753 864 974    
Depreciation EUR mil                         279 297 318 361 378    
EBIT EUR mil                         494 492 435 503 596    
Financing Cost EUR mil                         75.2 65.3 72.7 71.4 69.6    
Extraordinary Cost EUR mil                         15.6 4.66 -45.6 -13.8 -1.32    
Pre-Tax Profit EUR mil                         403 422 408 446 528    
Tax EUR mil                         114 107 91.3 126 132    
Minorities EUR mil                         16.0 21.7 21.2 14.3 22.7    
Net Profit EUR mil                         273 294 295 305 373    
growth rates                                      
Total Revenue Growth % ...                       9.51 2.41 5.03 12.9 5.57    
Operating Cost Growth % ...                       8.43 2.50 6.57 11.2 4.88    
EBITDA Growth % ...                       11.6 2.15 -4.67 14.8 12.7    
EBIT Growth % ...                       12.2 -0.302 -11.7 15.7 18.5    
Pre-Tax Profit Growth % ...                       11.1 4.80 -3.51 9.29 18.5    
Net Profit Growth % ...                       14.2 7.74 0.470 3.48 22.2    
ratios                                      
ROE %                         12.5 12.5 11.8 11.2 12.3    
ROCE % ...                       5.67 5.60 5.06 4.83 5.47    
Gross Margin %                         81.8 81.8 81.4 80.6 81.1    
EBITDA Margin %                         15.3 15.3 13.9 14.1 15.0    
EBIT Margin %                         9.78 9.53 8.01 8.21 9.21    
Net Margin %                         5.40 5.68 5.44 4.98 5.77    
Cost of Financing % ...                       5.43 4.16 3.99 3.77 3.56    
Net Debt/EBITDA                         1.63 2.20 2.35 2.15 1.95    
balance sheet Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
balance sheet                                      
Non-Current Assets EUR mil                         3,366 3,972 4,437 4,848 5,413    
Property, Plant & Equipment EUR mil                         2,737 2,897 3,303 3,642 3,987    
Intangible Assets EUR mil                         337 386 515 567 623    
Goodwill EUR mil                         103 123 169 183 204    
Current Assets EUR mil                         2,118 2,108 2,330 2,419 2,569    
Inventories EUR mil                         874 902 1,006 1,057 1,135    
Receivables EUR mil                         938 948 974 1,015 1,062    
Cash & Cash Equivalents EUR mil                         109 38.9 100 63.0 90.5    
Total Assets EUR mil                         5,484 6,080 6,767 7,266 7,982    
Shareholders' Equity EUR mil                         2,259 2,445 2,564 2,900 3,172    
Of Which Minority Interest EUR mil                         159 172 180 190 206    
Liabilities EUR mil                         3,224 3,635 4,203 4,366 4,810    
Non-Current Liabilities EUR mil                         1,918 1,988 2,595 2,477 2,751    
Long-Term Debt EUR mil                         886 1,005 1,284 1,155 1,186    
Deferred Tax Liabilities EUR mil ... ... ... ... ... ... ... ... ... ... ... ... ... ... 84.1 99.7 109    
Current Liabilities EUR mil                         1,306 1,646 1,608 1,889 2,059    
Short-Term Debt EUR mil                         483 769 586 768 806    
Trade Payables EUR mil                         242 271 306 390 487    
Equity And Liabilities EUR mil                         5,484 6,080 6,767 7,266 7,982    
growth rates                                      
Total Asset Growth % ...                       6.67 10.9 11.3 7.38 9.85    
Shareholders' Equity Growth % ...                       7.52 8.22 4.87 13.1 9.36    
Net Debt Growth % ...                       -7.12 37.7 2.03 5.10 2.22    
Total Debt Growth % ...                       -2.34 29.6 5.43 2.85 3.58    
ratios                                      
Total Debt EUR mil                         1,369 1,774 1,870 1,923 1,992    
Net Debt EUR mil                         1,260 1,735 1,770 1,860 1,902    
Working Capital EUR mil                         1,570 1,578 1,674 1,682 1,709    
Capital Employed EUR mil                         4,935 5,549 6,111 6,529 7,123    
Net Debt/Equity                         0.558 0.710 0.690 0.641 0.600    
Cost of Financing % ...                       5.43 4.16 3.99 3.77 3.56    
cash flow Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
cash flow                                      
Net Profit EUR mil                         273 294 295 305 373    
Depreciation EUR mil                         279 297 318 361 378    
Non-Cash Items EUR mil ...                       109 -41.8 319 58.0 113    
Change in Working Capital EUR mil ...                       57.3 -8.25 -96.1 -7.71 -27.8    
Total Cash From Operations EUR mil                         718 541 836 717 836    
Capital Expenditures EUR mil                         -502 -567 -663 -696 -740    
Other Investments EUR mil                         0 0 0 0 0    
Total Cash From Investing EUR mil                         -502 -567 -663 -696 -740    
Dividends Paid EUR mil                         0 0 0 0 0    
Issuance Of Shares EUR mil ...                       -115 -108 -176 30.9 -102    
Issuance Of Debt EUR mil ...                       -32.7 405 96.4 53.2 68.8    
Total Cash From Financing EUR mil                         216 -25.8 173 21.3 96.2    
Net Change In Cash EUR mil                         432 -51.7 347 42.6 192    
ratios                                      
Days Sales Outstanding days                         67.9 66.9 65.5 60.4 59.9    
Days Sales Of Inventory days                         347 350 363 325 340    
Days Payable Outstanding days                         96.3 105 110 120 146    
Cash Conversion Cycle days                         319 312 318 266 254    
Cash Earnings EUR mil                         552 591 613 667 751    
Cash Earnings Per Share EUR                         28.4 30.5 31.6 34.4 38.7    
Free Cash Flow EUR mil                         216 -25.8 173 21.3 96.2    
other data Unit 2000 2001 2002 2003 2004 2005 2006 2007 2008 2009 2010 2011 2012 2013 2014 2015 2016 2017 2018
other data                                      
ROA %                         5.13 5.08 4.60 4.35 4.90    
Gross Margin %                         81.8 81.8 81.4 80.6 81.1    
Cost Per Employee USD per month                         4,219 4,180 4,039 3,874 3,676    
Cost Per Employee (Local Currency) EUR per month                         3,283 3,149 3,134 3,380 3,429    
Staff Cost (As % Of Total Cost) %                         40.3 40.3 40.7 40.2 40.6    
Effective Tax Rate %                         28.4 25.3 22.4 28.2 25.0    

Get all company financials in excel:

Download Sample   $19.99

Finance

B Braun Melsungen has been growing its sales by a year on average in the last 5 years. EBITDA has grown by 0% during that time to total of in 2018, or of sales. That’s compared to % average margin seen in last five years.

The company netted in 2018 implying ROE of and ROCE of . Again, the average figures were % and %, respectively when looking at the previous 5 years.

B Braun Melsungen’s net debt amounted to at the end of 2018, or of equity. When compared to EBITDA, net debt was x, up when compared to average of x seen in the last 5 years.

More Companies in German Pharmaceutical Sector

Helgi Library
Eliášova 38, Prague 6, 160 00, Czech Republic
Copyright © 2025 Helgi Library. All rights reserved.